NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Chapter 8 – Monitoring: long-term care<br />
Figure 8.1: The monitoring cycle<br />
SET<br />
TARGET<br />
IOP<br />
Establish<br />
baselines<br />
Consider<br />
need to alter<br />
targets or<br />
intervention<br />
DIAGNOSIS<br />
Commence<br />
intervention<br />
Monitor<br />
response to<br />
intervention<br />
Medical history<br />
The collection of information from patients being monitored for glaucoma progression should include<br />
an adequate history of the patient’s health since last visit, as well as questions regarding ocular<br />
history, new systemic medications, and any side effects from ocular medications since last assessment.<br />
Frequency and time of the last IOP-lowering medication administration and review of use of systemic<br />
medications should also be included (American Optometric Association [AOA] 2002).<br />
Assessing a patient’s capacity to adhere to a medication regimen is essential, otherwise medication<br />
management may need to be escalated, on an assumption of medically unresponsive glaucoma.<br />
Health care providers should thus develop a patient-by-patient understanding of the factors<br />
associated with individual adherence to glaucoma management strategies. Health care providers<br />
should then develop strategies in partnership with the patient to assist in addressing barriers to<br />
ongoing adherence with management programs. Understanding the patient’s social and behavioural<br />
responses to a diagnosis of a chronic eye condition such as glaucoma is essential. This enables<br />
health care providers to assist the patient to manage their condition in the best possible manner<br />
for them. This optimises the patient’s quality of life, and reduces complications and the likelihood<br />
of deterioration of their condition. Accurate and timely information on the patient’s use of<br />
prescription and over-the-counter medications for other health conditions is essential, as is an<br />
understanding of the patient’s capacity to self-administer and to pay for glaucoma medications.<br />
This guideline provides ideas regarding Questions to Ask Your Patient at the end of this chapter.<br />
Evidence Statement<br />
• Evidence strongly supports taking a comprehensive history at each review. This should include information<br />
on what has occurred in the intervening period, and the patient’s ability to adhere to the prescribed<br />
medication regimen.<br />
92 National Health and Medical Research Council